ARIX.L

Arix Bioscience Plc
Arix Bioscience Plc - Total Voting Rights
5th May 2023, 15:30
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6272Y
Arix Bioscience Plc
05 May 2023
 

Arix Bioscience plc
( the "Company")

05 May 2023

Total Voting Rights

The Company confirms that its total issued share capital at the close of business on 4 May 2023 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 6,220,145 Ordinary Shares which are held in Treasury, leaving a balance of 129,389,508 Ordinary Shares with each share carrying the right to one vote.        

 

The above figure of 129,389,508 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules.

 

 

 

For further information please contact:

Kin Company Secretarial Limited, Company Secretary

+44 20 8819 6486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPURPAUPWGWA ]]>
TwitterFacebookLinkedIn